Intelligent Bio Solutions (NASDAQ:INBS – Get Free Report) and NeuroOne Medical Technologies (NASDAQ:NMTC – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.
Profitability
This table compares Intelligent Bio Solutions and NeuroOne Medical Technologies’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Intelligent Bio Solutions | -296.73% | -176.09% | -89.71% |
| NeuroOne Medical Technologies | -68.35% | -99.43% | -70.40% |
Analyst Recommendations
This is a summary of current ratings and recommmendations for Intelligent Bio Solutions and NeuroOne Medical Technologies, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Intelligent Bio Solutions | 1 | 0 | 0 | 0 | 1.00 |
| NeuroOne Medical Technologies | 1 | 1 | 3 | 0 | 2.40 |
Valuation & Earnings
This table compares Intelligent Bio Solutions and NeuroOne Medical Technologies”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Intelligent Bio Solutions | $3.05 million | 1.76 | -$10.57 million | ($12.22) | -0.18 |
| NeuroOne Medical Technologies | $12.10 million | 2.40 | -$3.61 million | ($0.85) | -3.93 |
NeuroOne Medical Technologies has higher revenue and earnings than Intelligent Bio Solutions. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
33.0% of Intelligent Bio Solutions shares are owned by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. 1.3% of Intelligent Bio Solutions shares are owned by insiders. Comparatively, 11.8% of NeuroOne Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Risk & Volatility
Intelligent Bio Solutions has a beta of 4.21, suggesting that its share price is 321% more volatile than the S&P 500. Comparatively, NeuroOne Medical Technologies has a beta of 0.51, suggesting that its share price is 49% less volatile than the S&P 500.
Summary
NeuroOne Medical Technologies beats Intelligent Bio Solutions on 11 of the 14 factors compared between the two stocks.
About Intelligent Bio Solutions
Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
About NeuroOne Medical Technologies
NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.
Receive News & Ratings for Intelligent Bio Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Bio Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
